3 Biotech Stocks With Major Catalysts Incoming

The closing weeks of summer could heat up for a few biotechs with experimental new therapies getting close to the finish line. TG Therapeutics, Inc. (NASDAQ:TGTX) and Sangamo Therapeutics, Inc. (NASDAQ:SGMO) will reveal some hotly anticipated clinical trial results in the weeks ahead. Akcea Therapeutics, Inc. (NASDAQ:AKCA) is a lot closer to commercializing its first product in the U.S., but it's still relying on two approval decisions in its near future.